Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure adequate availability of (a) atomoxetine, (b) lisdexamfetamine, (c) methylphenidate and (d) other Attention Deficit Hyperactivity Disorder medication within (i) NHS Wales and (ii) Cwm Taf Morgannwg Health Board.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working hard with industry to help resolve those issues and expedite deliveries to boost supplies of medicines uses for the management of ADHD, as quickly as possible. We have been informed that these should largely be resolved by April or May 2024.
As a result of our ongoing activity and intensive work, some issues have been resolved. Certain strengths of lisdexamphetamine, guanfacine, and all strengths of atomoxetine capsules are now available. While supply issues remain for some ADHD medicines, we continue to escalate these issues with manufacturers to ensure action is taken to resolve regulatory issues and expedite deliveries, to alleviate these shortages as soon as possible.
Health is a devolved matter and as such decisions on availability of medicines in Wales are a matter for the devolved administrations. However, the Department works closely with suppliers, NHS England, the Medicines and Healthcare products Regulatory Agency, the devolved administrations, and other stakeholders to ensure patients continue to have access to the treatments they need.
The Department’s officials regularly discuss a range of issues with colleagues in the Welsh Health and Social Services, including on the access to medicines. The Department has had no specific discussions with the Welsh Minister for Health and Social Services.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 January 2024 to Question 8042 on Attention Deficit Hyperactivity Disorder: Drugs, whether it remains her Department's policy to resolve disruptions with the supply of ADHD medication by April 2024.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working hard with industry to help resolve those issues and expedite deliveries to boost supplies of medicines uses for the management of ADHD, as quickly as possible. We have been informed that these should largely be resolved by April or May 2024.
As a result of our ongoing activity and intensive work, some issues have been resolved. Certain strengths of lisdexamphetamine, guanfacine, and all strengths of atomoxetine capsules are now available. While supply issues remain for some ADHD medicines, we continue to escalate these issues with manufacturers to ensure action is taken to resolve regulatory issues and expedite deliveries, to alleviate these shortages as soon as possible.
Health is a devolved matter and as such decisions on availability of medicines in Wales are a matter for the devolved administrations. However, the Department works closely with suppliers, NHS England, the Medicines and Healthcare products Regulatory Agency, the devolved administrations, and other stakeholders to ensure patients continue to have access to the treatments they need.
The Department’s officials regularly discuss a range of issues with colleagues in the Welsh Health and Social Services, including on the access to medicines. The Department has had no specific discussions with the Welsh Minister for Health and Social Services.
Asked by: Beth Winter (Labour - Cynon Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with the Welsh Minister for Health and Social Services on the availability of (a) atomoxetine, (b) lisdexamfetamine, (c) methylphenidate and (d) other ADHD medication.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working hard with industry to help resolve those issues and expedite deliveries to boost supplies of medicines uses for the management of ADHD, as quickly as possible. We have been informed that these should largely be resolved by April or May 2024.
As a result of our ongoing activity and intensive work, some issues have been resolved. Certain strengths of lisdexamphetamine, guanfacine, and all strengths of atomoxetine capsules are now available. While supply issues remain for some ADHD medicines, we continue to escalate these issues with manufacturers to ensure action is taken to resolve regulatory issues and expedite deliveries, to alleviate these shortages as soon as possible.
Health is a devolved matter and as such decisions on availability of medicines in Wales are a matter for the devolved administrations. However, the Department works closely with suppliers, NHS England, the Medicines and Healthcare products Regulatory Agency, the devolved administrations, and other stakeholders to ensure patients continue to have access to the treatments they need.
The Department’s officials regularly discuss a range of issues with colleagues in the Welsh Health and Social Services, including on the access to medicines. The Department has had no specific discussions with the Welsh Minister for Health and Social Services.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the preparedness of intensive care services for a future pandemic.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department continues to plan and prepare for a range of pandemic and emerging infectious disease scenarios, including those caused by respiratory contact, both influenza and non-influenza, and vector-borne pathogens, building on lessons learned from exercises and incidents, including the COVID-19 pandemic. The Department working with health and care partners is strengthening pandemic preparedness by considering the flexible and scalable response capabilities that can be adapted to any threat that the health and social care system needs.
This includes intensive care capacity that will continue to be an integral part of National Health Service resilience and pandemic planning. The urgent and emergency care recovery plan this year sought to strengthen capacity within the acute bed base, with 5,000 additional permanent staffed core general and acute beds delivered, compared to planned 2022/23 levels. Our preparedness also includes considering the medicines and other supporting products for intensive care services in a pandemic.
Asked by: Duncan Baker (Conservative - North Norfolk)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, how many starts by region have been recorded for the youth offer as of 01 March 2024.
Answered by Mims Davies - Minister of State (Department for Work and Pensions)
The Youth Offer launched on the 20 September 2020 and provides support for 16–24-year-olds who are on Universal Credit to help them move into employment. It includes three elements:
As of 01 March 2024, there have been 1,123,000 starts on the Youth Offer.
Starts by strand nationally:
Starts between dates | Youth Employment Programme | Youth Hub | Youth Employability Coach | Youth Offer |
21/09/2020 – 31/03/2021 | 206,700 |
|
| 206,700 |
01/04/2021 – 31/03/2022 | 259,300 | 14,800 | 21,700 | 295,800 |
01/04/2021 – 31/03/2023 | 272,700 | 15,100 | 18,300 | 306,200 |
01/04/2023 – 29/02/2024 | 282,800 | 13,000 | 18,500 | 314,300 |
Total Starts | 1,021,500 | 43,000 | 58,500 | 1,123,000 |
Starts by strand and region:
Region | Youth Employment Programme | Youth Hub | Youth Employability Coach | Youth Offer |
East Midlands | 69,000 | 1,000 | 2,500 | 72,500 |
East of England | 78,400 | 400 | 3,800 | 82,500 |
London | 157,800 | 3,100 | 5,900 | 166,800 |
North East | 51,100 | 2,800 | 3,300 | 57,200 |
North West | 131,500 | 10,700 | 9,600 | 151,800 |
Scotland | 85,300 | 3,000 | 7,900 | 96,200 |
South East | 107,000 | 3,700 | 3,800 | 114,600 |
South West | 64,700 | 700 | 4,100 | 69,500 |
Wales | 51,500 | 300 | 2,200 | 54,000 |
West Midlands | 108,900 | 8,900 | 7,800 | 125,600 |
Yorkshire and The Humber | 96,400 | 8,200 | 7,300 | 112,000 |
Unknown | 19,800 | 200 | 400 | 20,400 |
Total | 1,021,500 | 43,000 | 58,500 | 1,123,000 |
Notes:
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average (a) daily cost per adult held in the emergency department and (b) length of stay was in that department in the latest period for which data is available in each acute trust within the Lancashire and South Cumbria integrated care system boundary.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The information is not available in the format requested. NHS England published the general and acute length of bed stay data for 2022/23, with data available at trust level but not an integrated care system level, which is available at the following link:
The length of stay in an adult intensive care unit hospital bed and an elderly care hospital bed is not collected centrally by the Department, or published by NHS England. NHS England publishes the median total time spent in accident and emergency, from arrival to admission, transfer, or discharge, and again with data available at trust level but not an integrated care system level, which is available at the following link:
The information requested on average daily costs by acute trust and integrated care system is not collected centrally by the Department.
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average (a) daily cost is per adult elderly care hospital bed and (b) length of stay was in those beds in the latest period for which data is available in each acute trust within the Lancashire and South Cumbria integrated care system boundary.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The information is not available in the format requested. NHS England published the general and acute length of bed stay data for 2022/23, with data available at trust level but not an integrated care system level, which is available at the following link:
The length of stay in an adult intensive care unit hospital bed and an elderly care hospital bed is not collected centrally by the Department, or published by NHS England. NHS England publishes the median total time spent in accident and emergency, from arrival to admission, transfer, or discharge, and again with data available at trust level but not an integrated care system level, which is available at the following link:
The information requested on average daily costs by acute trust and integrated care system is not collected centrally by the Department.
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average (a) daily cost is for an adult intensive care unit hospital bed and (b) length of stay was in those beds in the latest period for which data is available in each acute trust within the Lancashire and South Cumbria integrated care system boundary.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The information is not available in the format requested. NHS England published the general and acute length of bed stay data for 2022/23, with data available at trust level but not an integrated care system level, which is available at the following link:
The length of stay in an adult intensive care unit hospital bed and an elderly care hospital bed is not collected centrally by the Department, or published by NHS England. NHS England publishes the median total time spent in accident and emergency, from arrival to admission, transfer, or discharge, and again with data available at trust level but not an integrated care system level, which is available at the following link:
The information requested on average daily costs by acute trust and integrated care system is not collected centrally by the Department.
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average (a) cost per adult and (b) length of stay was for an acute hospital bed day in each acute trust within the Lancashire and South Cumbria integrated care system in the 2022-2023 financial year.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The information is not available in the format requested. NHS England published the general and acute length of bed stay data for 2022/23, with data available at trust level but not an integrated care system level, which is available at the following link:
The length of stay in an adult intensive care unit hospital bed and an elderly care hospital bed is not collected centrally by the Department, or published by NHS England. NHS England publishes the median total time spent in accident and emergency, from arrival to admission, transfer, or discharge, and again with data available at trust level but not an integrated care system level, which is available at the following link:
The information requested on average daily costs by acute trust and integrated care system is not collected centrally by the Department.
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average (a) cost per adult and (b) length of stay was for an acute hospital bed day in the Lancashire and South Cumbria integrated care system in the 2022-2023 financial year.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The information is not available in the format requested. NHS England published the general and acute length of bed stay data for 2022/23, with data available at trust level but not an integrated care system level, which is available at the following link:
The length of stay in an adult intensive care unit hospital bed and an elderly care hospital bed is not collected centrally by the Department, or published by NHS England. NHS England publishes the median total time spent in accident and emergency, from arrival to admission, transfer, or discharge, and again with data available at trust level but not an integrated care system level, which is available at the following link:
The information requested on average daily costs by acute trust and integrated care system is not collected centrally by the Department.